Bionomics Limited

NASDAQ:BNOX

0.21 (USD) • At close October 29, 2024
Bedrijfsnaam Bionomics Limited
Symbool BNOX
Munteenheid USD
Prijs 0.215
Beurswaarde 4,723,468
Dividendpercentage 0%
52-weken bereik 0.177 - 2.84
Industrie Biotechnology
Sector Healthcare
CEO Dr. Spyridon Papapetropoulos M.D., Ph.D.
Website https://www.bionomics.com.au

An error occurred while fetching data.

Over Bionomics Limited

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2

Vergelijkbare Aandelen

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

SCYX

1.4 USD

Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

BOLT

0.67 USD

Qilian International Holding Group Limited logo

Qilian International Holding Group Limited

QLI

5.41 USD

Novo Integrated Sciences, Inc. logo

Novo Integrated Sciences, Inc.

NVOS

0.192 USD

InflaRx N.V. logo

InflaRx N.V.

IFRX

1.565 USD

DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc.

DMAC

4.32 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)